Pittsburgh Xarelto Lawsuits Filed For Negative Side Effects
Medical Studies Show The Dangers Of Xarelto There have been a number of medical studies performed that have linked the heavily marketed... Read More
Xarelto Internal Bleeding Incidents Lawsuit In New Mexico
Xarelto is an anticoagulant produced by pharmaceutical companies, Bayer and Johnson & Johnson. This blood thinner has been highly publicized and endorsed... Read More
Xarelto Internal Bleeding Injuries Lawsuit Filed In Mississippi
Xarelto is a highly popular blood thinner drug that has seen over 11 million scripts written in all of America. Xarelto is... Read More
Wyoming Xarelto Related Internal Bleeding Lawsuit
The anticoagulant Xarelto is a blood thinning drug that is designed to minimize the chances of an individual suffering a stroke if... Read More
Xarelto Lawsuit Filed In Delaware For Internal Bleeding Injuries
What Makes Xarelto Different? Xarelto is an anticoagulant drug or blood thinner that is heavily marketed, as seen by its television advertisement... Read More
Hawaii Xarelto Bleeding Events Lawsuit
Xarelto is a popular anticoagulant on the market that is marketed as “one-size-fits-all” type of drug, unlike the older anticoagulants, like Warfarin... Read More
The Xarelto Lawsuit In Arkansas For Internal Bleeding Injuries
What Is Xarelto? Xarelto or Rivaroxaban, is one of the latest blood thinners available on the market. Xarelto is an oral drug... Read More
Xarelto Alaska Lawsuit Filed For Internal Bleeding Injuries
What Are Blood Thinners Used For? Xarelto is a popular blood thinner that has been designed to decrease the potential of someone... Read More
New Hampshire Xarelto Internal Bleeding Lawsuit
Xarelto is a drug designed to help people with atrial fibrillation (AFib) and are at risk of blood clots forming in their... Read More
Xarelto Litigation For Internal Bleeding Incidents In Idaho
What Does Xarelto Do? Xarelto, also known as Rivaroxaban, is a drug that is a part of anticoagulant medications. Anticoagulants are used... Read More
